Drugmakers expect hit from Medicare drug plan (Reuters)


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/nm/20051109/hl_nm/summit_medicare_dc"><img src="http://us.news3.yimg.com/us.i2.yimg.com/p/nm/20051109/2005_11_09t120236_450x277_us_summit_medicare.jpg?x=130&y=80&sig=pmkLwf.qhnNl_o7oZg0GJw--" align="left" height="80" width="130" alt="Hank McKinnell, chief executive officer of Pfizer, speaks to reporters at the Reuters Health summit in New York November 7, 2005. (Chip East/Reuters)" border="0" /></a>Reuters - The new prescription drug benefit for
U.S. Medicare beneficiaries is likely to hurt drug makers in
the long term as insurers, pharmacies and elderly groups
offering the plans seek greater discounts, top pharmaceutical
executives said this week.</p><br clear=all>